XORTX Therapeutics Inc.
XRTXHealthcare|Biotechnology|CA
$0.91
+0.00 (+0.00%)
DCF Value
$0.39
Tangible Book / Share
$1.83
Cash / Share
$0.61
Financials
Financial Snapshot
Market Cap
$1.7M
Enterprise Value
$660.2K
Revenue (TTM)
$0.00
Net Income (TTM)
-$3.7M
Cash & Investments
$992.9K
Net Cash
$992.9K
Free Cash Flow (TTM)
-$1.9M
Operating CF (TTM)
-$5.0M
Debt/Equity
0.00
Cash Runway & Burn Rate
Cash on Hand
$992.9K
Quarterly Burn
$1.3M
Monthly Burn
$417.1K
Est. Runway
~0.8 quarters
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $166.5K | $61.9K | $260.0K | $806.3K | $171.3K | $14.9M | $10.4M | $3.4M | $2.5M | $862.9K | $992.9K | |
| Operating Cash Flow | -$141.3K | $72.5K | -$920.6K | -$191.1K | -$728.4K | -$4.8M | -$9.0M | -$6.6M | -$3.7M | -$2.8M | -$5.0M | |
| Free Cash Flow | -$145.1K | $62.6K | -$1.2M | -$196.4K | -$742.8K | -$4.8M | -$9.0M | -$6.6M | -$3.7M | -$2.8M | -$1.9M | |
| Capital Expenditure | -$3.8K | -$9.9K | -$30.2K | -$5.4K | -$11.3K | -$31.8K | -$45.7K | -$46.4K | -$38.9K | $3.00 | $3.1M | |
| Financing Cash Flow | $115.0K | $133.7K | $1.9M | $55.2K | $855.4K | $19.4M | $3.9M | -$361.0K | $2.8M | $1.5M | $5.3M |
R&D Spending
R&D (TTM)
$259.8K
R&D Intensity
—
R&D Growth vs Prior
-54.8%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| R&D Expense | $0.00 | $66.4K | $342.3K | $39.9K | $277.5K | $856.8K | $9.2M | $2.4M | $175.0K | $574.9K | $259.8K | |
| SG&A | $389.3K | $380.9K | $795.7K | $506.2K | $804.8K | $2.0M | $3.3M | $2.2M | $3.6M | $1.8M | $1.9M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $19.9K | $0.00 | $18.0K | $0.00 | $0.00 | $111.6K | $0.00 | $29.6K | |
| Gross Profit | $0.00 | $0.00 | -$19.3K | -$19.9K | $0.00 | -$18.0K | $0.00 | $0.00 | -$111.6K | $0.00 | -$29.6K | |
| R&D | $0.00 | $66.4K | $342.3K | $39.9K | $277.5K | $856.8K | $9.2M | $2.4M | $175.0K | $574.9K | $259.8K | |
| SG&A | $389.3K | $380.9K | $795.7K | $506.2K | $804.8K | $2.0M | $3.3M | $2.2M | $3.6M | $1.8M | $1.9M | |
| Operating Income | -$389.3K | -$427.1K | -$1.1M | -$566.0K | -$1.1M | -$3.7M | -$12.4M | -$6.0M | -$3.9M | -$3.3M | -$3.9M | |
| Interest Expense | $8.6K | $15.5K | $22.3K | $38.2K | $12.7K | $5.6K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Pretax Income | -$414.8K | -$474.2K | -$3.8M | -$629.6K | -$1.3M | -$1.7M | -$10.5M | -$2.2M | -$3.2M | -$2.7M | -$3.7M | |
| Net Income | -$414.8K | -$474.2K | -$3.8M | -$629.6K | -$1.3M | -$1.7M | -$10.5M | -$2.2M | -$3.2M | -$2.7M | -$3.7M | |
| EPS (Diluted) | -58.00 | -55.75 | -150.75 | -25.25 | -8.67 | -9.13 | -176.55 | -5.45 | -5.48 | -2.80 | -2.74 | |
| EBITDA | -$389.3K | -$430.5K | -$1.1M | -$572.8K | -$1.1M | -$2.9M | -$12.4M | -$5.9M | -$3.8M | -$3.1M | -$3.8M | |
| Shares Out. (M) | 0.01 | 0.01 | 0.03 | 0.03 | 0.15 | 0.22 | 0.06 | 0.40 | 0.58 | 0.95 | 1.62 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166.5K | $49.3K | $190.9K | $58.6K | $171.3K | $14.9M | $10.4M | $3.4M | $2.5M | $862.9K | $992.9K | |
| Short-Term Investments | $0.00 | $12.7K | $69.1K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $18.3K | $63.5K | $979.6K | $822.2K | $2.1M | $15.9M | $10.9M | $4.1M | $2.7M | $965.5K | $2.4M | |
| Total Assets | $282.5K | $490.6K | $1.3M | $1.1M | $2.3M | $17.4M | $12.4M | $5.5M | $4.1M | $2.7M | $6.2M | |
| Total Current Liabilities | $599.5K | $1.1M | $900.4K | $1.3M | $1.0M | $552.9K | $1.5M | $825.9K | $758.0K | $598.0K | $678.7K | |
| Long-Term Debt | $0.00 | $28.4K | $43.3K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Liabilities | $599.5K | $1.1M | $943.7K | $1.3M | $1.0M | $4.2M | $5.4M | $825.9K | $758.0K | $598.0K | $678.7K | |
| Stockholders' Equity | -$317.1K | -$654.6K | $321.5K | -$211.7K | $1.3M | $13.2M | $7.0M | $4.6M | $3.3M | $2.1M | $5.5M | |
| Retained Earnings | -$1.9M | -$1.9M | -$6.1M | -$6.8M | -$8.0M | -$8.0M | -$15.7M | -$17.9M | -$21.2M | -$23.8M | -$26.3M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$141.3K | $72.5K | -$920.6K | -$191.1K | -$728.4K | -$4.8M | -$9.0M | -$6.6M | -$3.7M | -$2.8M | -$5.0M | |
| Capital Expenditure | -$3.8K | -$9.9K | -$30.2K | -$5.4K | -$11.3K | -$31.8K | -$45.7K | -$46.4K | -$38.9K | $3.00 | $3.1M | |
| Free Cash Flow | -$145.1K | $62.6K | -$1.2M | -$196.4K | -$742.8K | -$4.8M | -$9.0M | -$6.6M | -$3.7M | -$2.8M | -$1.9M | |
| Investing Cash Flow | -$24.6K | -$179.7K | -$154.8K | -$5.4K | -$14.3K | -$31.8K | -$45.7K | -$46.4K | -$38.9K | -$300.1K | -$413.0K | |
| Financing Cash Flow | $115.0K | $133.7K | $1.9M | $55.2K | $855.4K | $19.4M | $3.9M | -$361.0K | $2.8M | $1.5M | $5.3M | |
| Issuance of Stock | $272.9K | $33.7K | $1.4M | $70.0K | $705.8K | $18.1M | $5.0M | $301.43 | $3.5M | $1.5M | $6.2M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $0.00 | $79.5K | $0.00 | $0.00 | $0.00 | $0.00 | -$20.4K | -$66.1K | $0.00 | -$89.6K | -$80.4K | |
| Stock Based Comp. | $218.88 | $92.7K | $275.1K | $26.3K | $293.4K | $576.0K | $487.9K | $121.0K | $122.5K | $25.2K | $17.1K | |
| Net Change in Cash | -$17.3K | $45.2K | $198.1K | -$201.4K | $112.7K | $14.7M | -$4.4M | -$7.0M | -$974.0K | -$1.7M | -$71.4K |
Dilution Tracker
Shares outstanding grew 539.4% over 5 years — significant dilution
Shares Outstanding
2M
5-Year Share Growth
+539.4%
Stock Issuance (TTM)
$6.2M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.01 | 0.01 | 0.03 | 0.03 | 0.15 | 0.22 | 0.06 | 0.40 | 0.58 | 0.95 | 1.62 | |
| Change vs Prior % | — | 19.2% | 194.4% | 0.0% | 491.5% | 47.8% | -73.0% | 569.6% | 45.3% | 64.5% | 70.8% | |
| Stock Issuance | $272.9K | $33.7K | $1.4M | $70.0K | $705.8K | $18.1M | $5.0M | $301.43 | $3.5M | $1.5M | $6.2M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $218.88 | $92.7K | $275.1K | $26.3K | $293.4K | $576.0K | $487.9K | $121.0K | $122.5K | $25.2K | $17.1K |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 130.8% | 72.4% | -1174.3% | 297.4% | -102.3% | -12.6% | -149.4% | -46.5% | -94.5% | -127.7% | -138.3% | |
| ROA % | -146.9% | -96.7% | -298.4% | -57.9% | -56.1% | -9.6% | -84.5% | -39.5% | -77.0% | -99.2% | -60.7% | |
| ROIC % | 201.8% | 99.2% | -293.1% | 367.7% | -86.1% | -21.9% | -113.8% | -129.9% | -116.2% | -153.7% | -71.4% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Gross Profit | 0.0% | 0.0% | 0.0% | -3.0% | 100.0% | 0.0% | 100.0% | 0.0% | 0.0% | 100.0% | |
| Operating Income | -59.6% | -9.7% | -150.4% | 47.1% | -91.2% | -239.8% | -238.1% | 51.4% | 35.2% | 17.0% | |
| Net Income | -48.5% | -14.3% | -696.3% | 83.3% | -104.0% | -29.6% | -527.7% | 79.4% | -46.2% | 15.8% | |
| EPS (Diluted) | -68.1% | 3.9% | -170.4% | 83.3% | 65.7% | -5.3% | -1833.7% | 96.9% | -0.6% | 48.9% | |
| Operating Cash Flow | -9.9% | 151.3% | -1369.7% | 79.2% | -281.2% | -559.1% | -86.7% | 26.6% | 44.1% | 23.4% | |
| Free Cash Flow | 13.5% | 143.1% | -1973.1% | 83.2% | -278.1% | -550.7% | -86.4% | 26.4% | 43.9% | 24.2% | |
| R&D Expense | 0.0% | 0.0% | 415.7% | -88.3% | 595.4% | 208.8% | 968.5% | -73.6% | -92.8% | 228.5% | |
| SG&A Expense | 59.6% | -2.2% | 108.9% | -36.4% | 59.0% | 154.2% | 60.2% | -32.0% | 63.1% | -49.6% | |
| Total Assets | 38.8% | 73.7% | 157.9% | -14.0% | 110.5% | 658.9% | -28.8% | -55.8% | -25.1% | -34.6% | |
| Book Value / Share | -282.0% | -73.4% | 116.7% | -165.8% | 200.4% | 613.5% | 95.2% | -90.1% | -50.5% | -62.1% | |
| Debt | 0.0% | 74.6% | -80.0% | 17.5% | -100.0% | 0.0% | 0.0% | -85.2% | 237.0% | -4.0% | |
| Diluted Shares | -11.8% | 19.2% | 194.4% | 0.0% | 491.5% | 47.8% | -73.0% | 569.6% | 45.3% | 64.5% |
Valuation
P/E (TTM)At Loss
P/S0.00
P/B0.27
10Y Low / Med / High0.42 / 1.28 / 9.21
EV/EBITDAAt Loss
EV/Revenue0.00
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$0.39
Tangible Book / Share
$1.83
Net Current Assets / Share
$0.97
Graham Net-Net
$0.23
Cash / Share
$0.61
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -1.75 | -1.71 | -0.44 | -3.55 | -9.02 | -12.77 | -0.28 | -2.12 | -1.03 | -1.00 | -0.33 | |
| P/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/B Ratio | -2.29 | -1.24 | 5.15 | -10.59 | 9.21 | 1.93 | 0.42 | 0.99 | 0.97 | 1.28 | 0.27 | |
| EV/EBITDA | -1.75 | -2.27 | -1.41 | -3.90 | -10.53 | -3.63 | 0.60 | -0.19 | -0.22 | -0.58 | -0.17 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
-5.65
Distress
Piotroski F-Score
1
Weak
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 |
|---|---|---|
| Revenue | $3.3M | $16.0M |
| Net Income | -$1.7M | $3.8M |
| EPS | $-1.75 | $4.00 |
| # Analysts (EPS) | 1 | 1 |
Dividends
Frequency
Quarterly
Recent Payments
| Ex-Date | Pay Date | Amount | Frequency |
|---|---|---|---|
| Jan 31, 2014 | Feb 17, 2014 | $0.00 | Quarterly |
| Oct 15, 2013 | Nov 1, 2013 | $0.00 | Quarterly |
| Jul 11, 2013 | Jul 30, 2013 | $0.00 | Quarterly |
| Apr 16, 2013 | May 2, 2013 | $0.00 | Quarterly |
| Dec 24, 2012 | Dec 31, 2012 | $0.00 | Quarterly |
| Oct 12, 2012 | Oct 30, 2012 | $0.00 | Quarterly |
| Jul 17, 2012 | Aug 1, 2012 | $0.00 | Quarterly |
| Apr 10, 2012 | Apr 26, 2012 | $0.00 | Special |
| Feb 13, 2012 | Feb 29, 2012 | $0.00 | Quarterly |
| Nov 22, 2011 | Dec 9, 2011 | $0.00 | Quarterly |
| Aug 10, 2011 | Aug 26, 2011 | $0.00 | Quarterly |